SCIO Scios Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SCIO Scios Inc.

SCIO 0.01000

0.0%

Aug 19 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BRAVEHEART who wrote (964)	1/11/1999 6:04:00 PM
From: jerryriti	of 1477

Scios has 2 major programs. A NDA has been filed with the FDA for Natrecor and approval should be forthcoming within weeks! This is the first new treatment for acute congestive heart failure in decades. There are various projections for the revenue stream, but I would have to do some digging into my notes. Suffice it to say, with approval, the market will develop rapidly(do not beleive they have signed on the dotted line for partnering on this product but could be wrong) Second program involves Fiblast for stroke. Truthfully, I am not up on the status of this program as I came into this stock vis a vis the Natrecor story! Scios has numerous collaborations with many drug houses and they market for others psychiatric medications (Paxil) which contributes modestly to its earnings. Sorry to be so sketchy, but wanted to give you a guideline!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next